Skip to main content
. 2019 Nov 13;367:l5919. doi: 10.1136/bmj.l5919

Table 2.

Network estimated mean differences (95% confidence intervals) in postoperative Qmax and IPSS values for new surgical methods compared with monopolar TURP for benign prostate hyperplasia

New surgical methods Time after surgery (months)
6 12 24 36
Qmax values (No of trials=45, 48, 18, and 14, respectively)
Bipolar TURP 0.66 (−0.60 to 1.92) 0.63 (−0.16 to 1.42) −0.19 (−2.14 to 1.76) 0.06 (−1.94 to 2.05)
Enucleation 1.52 (0.36 to 2.69)* 1.49 (0.59 to 2.40)* 1.92 (−0.22 to 4.05) 2.85 (0.13 to 5.57)*
Vapourisation −0.44 (−1.61 to 0.73) −0.21 (−1.19 to 0.76) −2.20 (−4.43 to 0.31) −1.98 (−4.92 to 0.97)
IPSS values (No of trials=45, 47, 17, 14, respectively)
Bipolar TURP 0.22 (−0.58 to 1.03) −0.17 (−0.72 to 0.37) −0.06 (−0.92 to 0.81) −0.22 (−1.11 to 0.79)
Enucleation −0.17 (−0.89 to 0.54) −0.84 (−1.40 to −0.27)* −0.83 (−1.79 to 0.12) −1.11 (−2.27 to 0.03)
Vapourisation 0.52 (−0.32 to 1.37) 0.24 (−0.45 to 0.94) 1.12 (−0.16 to 2.41) 0.33 (−1.03 to 1.70)

TURP=transurethral resection of the prostate; Qmax=maximal flow rate; IPSS=international prostate symptoms score. Enucleation includes bipolar EP, holmium LEP, thulium LEP, and diode LEP; vapourisation includes bipolar VP, KTP LVP, and diode LVP (abbreviations listed in table 1).

*

P<0.05.